{
  "created_at": "Mon Mar 22 22:51:26 +0000 2021",
  "id_str": "1374109913304154114",
  "full_text": "Pfizer and Moderna, which developed the same type of vaccine, announced efficacy rates of 94-95%. AstraZeneca says its vaccine was 79% effective at preventing symptomatic covid-19 https://t.co/AbK0eO4WYl",
  "display_text_range": [
    0,
    203
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/AbK0eO4WYl",
        "expanded_url": "https://econ.st/3se8w0a",
        "display_url": "econ.st/3se8w0a",
        "indices": [
          180,
          203
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 28,
  "favorite_count": 101,
  "possibly_sensitive": false,
  "original_created_at": "Mon Mar 22 21:25:07 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "开发同类型疫苗的辉瑞公司和Moderna公司公布的疗效率为94-95%。阿斯利康公司称，其疫苗在预防症状性covid-19 https://t.co/AbK0eO4WYl，有效率为79%。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "開發同類型疫苗的輝瑞公司和Moderna公司公佈的療效率爲94-95%。阿斯利康公司稱，其疫苗在預防症狀性covid-19 https://t.co/AbK0eO4WYl，有效率爲79%。"
    }
  ]
}